´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷) : 2019-05-18±³À°ÀÏÀÚ : 2019-05-18
±³À°Àå¼Ò : ÇÏÀÌ¿ø±×·£µåÈ£ÅÚ ÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ ¿Ü 2°³·ë
±³À°ÁÖÁ¦ :
Á¦28Â÷ Ãá°èÇмú´ëȸ ¹× ÃÑȸ(2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇÑ¿µ»óÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ
´ã´çÀÚ : ÁÖÇýÁ¤
¿¬¶ôó : 02-465-9070
À̸ÞÀÏ :
office@intervention.or.kr ±³À°Á¾·ù : ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаúÀÇ»çÇÐ, ÀÇ·áÄ¿¹Â´ÏÄÉÀ̼Ç, ÀÇÇб³À°, ÀÇ·áÁ¤Ã¥
Âü¼®¿¹»óÀοø : 350¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
°¿øµµ±³À°½Ã°£ : 10 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï:Á¤È¸¿ø 50000¿ø, Àü¹®ÀÇ 100000¿ø, °øº¸.Àü°øÀÇ 30000¿ø, ÁØȸ¿ø 50000¿ø/ÇöÀåµî·Ï: Á¤È¸¿ø 70000¿ø, Àü¹®ÀÇ 120000¿ø, °øº¸.Àü°øÀÇ 50000¿ø, ÁØȸ¿ø 70000¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 08:00~08:10 Percutaneous Endovascular Treatment of Dysfunctional Native Arteriovenous Fistulas: Transjugular versus Conventional Approach À̵¿±Ô(°í·ÁÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 08:10~08:20 Percutaneous transluminal angioplasty using direct puncture technique for failed cannulation in native hemodialysis arteriovenous fistula occlusion. ³ë½Â¿¬(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 08:20~08:30 Outcomes of drug-coated balloon treatment for femoro-popliteal artery occlusive disease ±è¶õ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 08:30~08:40 Mechanical thrombectomy using Rotarex device in arterial thrombosis ¡°Target Sign¡± in CT angiography ±èÇü¿í(Àü³²ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 08:40~08:50 Impact of subcutaneous tunnels on peripherally inserted catheter placement: a multicenter retrospective study ½Éµ¿Àç(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 08:50~09:00 Over-the-wire Deployment Techniques of Option Elite Inferior Vena Cava Filter: 3D Printing Vena Cava Phantom Study ¹Úº´°Ç(°æºÏÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 09:00~09:15 tPA ÀÌÀÎÁØ(±¹¸³¾Ï¼¾ÅÍ)
Åä·Ð 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 09:15~09:25 Discussion ()
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 09:25~09:45 Microballoon-related interventions in body trunk lesions Terumitsu Hasebe(Hachioji Hospital Tokai University)
Åä·Ð 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 09:45~09:55 Discussion ()
ÈÞ½Ä 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 09:55~10:15 Coffee Break ()
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 10:15~10:50 Key Points of AVMs Management µµ¿µ¼ö(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 10:50~11:20 IR Primary Specialty in The USA: 7 Years Later John A. Kaufman(Oregon Health & Science University)
Åä·Ð 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 11:20~11:30 Discussion ()
±âŸ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 11:30~12:10 ÃÑȸ ()
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 12:10~12:20 New roles of DCB in BTK – Lutonix¢ç BTK Trial ¿øÁ¦È¯(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 12:20~12:30 Stent vs stent-graft placement for aortoiliac arteries ¹Ú»ó¿ì(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 12:30~12:50 LIFESTREAM¢ç covered stent for AIOD and the BOLSTER study outcomes Peter Drescher(West Allis Memorial Hospital)
ÈÞ½Ä 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 12:50~13:10 Coffee Break ()
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:10~13:20 Clinical Outcomes of Transcatheter Arterial Embolization for Chronic Knee Pain: Severe Versus Mild to Moderate Knee Osteoarthritis ±èÅÂÈ£(±¹±º¼öµµº´¿ø)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:20~13:30 Management of life-threatening aortoesophageal fistula: Experiences learned eight patients ±èÁ¾¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:30~13:40 Çѱ¹¿Ü»óÀÎÅͺ¥¼Ç ·¹Áö½ºÆ®¸®ÀÇ Áß°£°á°ú º¸°í 2018 Å×·ç¸ðÁ¤Ã¥°úÁ¦ Àüâȣ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:40~13:50 Efficacy and Safety of the Prostate Artery Embolization in Patients wiTH BPH: One-year Follow Up ¹Ú»óÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 13:50~14:00 Endovenous Thermal Ablation of Recurrent Varicose Veins Due to Residual Great Saphenous Venous Insufficiency after Saphenous Venous Surgery: A Comparative Study ¹ÎÁö¿µ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:00~14:10 Effects of Irreversible Electroporation on Nerves: Functional and Histologic Evaluation in a Rabbit Model ±ÇÁØÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:10~14:20 Transradial Experience in TACE ±èÁ¾¿ì(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:20~14:30 Transradial Experience beyond Liver ÃÖÁø¿ì(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:30~14:40 Snuffbox Transradial Access Á¶¼ö¹ü(ÀÌÈÀÇ´ë)
Åä·Ð 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:40~14:50 Discussion Á¶¼º±â, ¿ÀÁö¿µ, ÀÌ»óȯ(¼º±Õ°üÀÇ´ë, °æÈñÀÇ´ë, ¾çÁöº´¿ø)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 14:50~15:10 Budd-Chiari syndrome: East vs. West Pengxu Ding(First Affiliated Hospital of Zhengzhou University)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:10~15:22 Use of Onyx in type I and type II endoleaks ±ÇÁØÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:22~15:34 Primary insertion of balloon-type enterostomy ±Ç¿äÇÑ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:34~15:46 An update on pulmonary AVM ÀÌ»ó¿±(°æºÏÀÇ´ë)
Åä·Ð 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ÄÁº¥¼ÇȦ 15:46~16:00 Discussion Çѱââ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ »çÆÄÀ̾î·ë 11:00~12:10 Peripheral Arterial Intervention Hands-on Education ¿øÀ¯µ¿, ȲÁøÈ£(°¡Å縯ÀÇ´ë, °Ç±¹ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 08:00~08:15 RF ablation for early stage HCC: updates À̵¿È£(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 08:15~08:30 Microwave ablation for early HCC: Early experiance in Korea È«ÇöÇ¥(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 08:30~08:45 Cryoablation for early HCC: updates °Å¿í(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 08:45~09:00 Intra-arterial Therapy for early HCC: updates °¾çÁØ(Àü³²ÀÇ´ë)
Åä·Ð 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 09:00~09:20 Panel discussion ÀÌÁ¤°æ, ¾öÁØ¿µ(ÀÌÈÀÇ´ë, Ãæ³²ÀÇ´ë)
ÈÞ½Ä 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 09:20~09:40 Coffee Break ()
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 09:40~09:55 TARE for HCC with PV thrombosis ±è°æ¹Î(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 09:55~10:10 Radiation therapy for HCC with PV thrombosis À±»ó¹Î(¿ï»êÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 10:10~10:25 Oncolytic virus therapy for advanced HCC ±èâ¿ø(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 10:25~10:40 Current new drugs for advanced HCC ÀüÈ«Àç(Â÷ÀÇ´ë)
Åä·Ð 05-18 ÇÏÀÌ¿ø±×·£µåÈ£ÅÚÄÁº¥¼ÇŸ¿ö 5Ãþ ¿¡¸Þ¶öµå·ë 10:40~11:00 Panel discussion Á¤µ¿Áø, ÀÌÀÎÁØ(°¡Å縯ÀÇ´ë, ±¹¸³¾Ï¼¾ÅÍ)